Codexis (CDXS)
Builds enzyme platforms for RNA manufacturing and pharma biocatalysis.
$1.39
After hours−0.02 (−1.07%)
At close$1.41(+1.81%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 59.32% | 64.96M shares | |
|---|---|---|---|
| 151 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 6.23% | 6.82M shares | |
| 14 holders · as of Jun 11, 2026 | |||
| Strategic holders | 11.60% | 12.70M shares | |
| 2 holders · as of Apr 14, 2026 | |||
| Other | ≈ 22.85% | 25.02M shares | |
| remainder | |||
109.51M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
151 holders · 64.96M shares · 28 new positions · 89 increased · 36 reduced · 13 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.28M | 6.65% | +255.6K | Aug 7, 2026 |
| Opaleye Management Inc. | 6.79M | 6.20% | 0 | Aug 14, 2026 |
| Abrdn PLC | 6.77M | 6.18% | −1.91M | Jul 31, 2026 |
| Millennium Management LLC | 5.55M | 5.07% | +1.55M | Aug 14, 2026 |
| Telemark Asset Management, LLC | 3.85M | 3.51% | 0 | Aug 10, 2026 |
| Ameriprise Financial Inc | 3.81M | 3.48% | +408.9K | Aug 14, 2026 |
| Nantahala Capital Management, LLC | 3.62M | 3.31% | −500.0K | Aug 19, 2026 |
| Vanguard Capital Management LLC | 3.62M | 3.30% | −51.4K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Aberdeen Group plc | 8.82% | 7.97M | 13G | Jan 15, 2026 |
| Opaleye Management Inc. | 7.47% | 6.79M | 13G | May 5, 2026 |
| Telemark Asset Management, LLC | 7.30% | 7.85M | 13G | Jul 29, 2026 |
| BlackRock, Inc. | 7.20% | 5.98M | 13G | Apr 24, 2025 |
| Integrated Core Strategies (US) LLC | 5.20% | 4.73M | 13G | Apr 14, 2026 |
| Lytton Laurence W | 5.00% | 4.53M | 13G | Mar 11, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 11, 2026 | Raymond de Vredirector | Sale | 2,605 | $2.37 | 84,811 |
| Feb 24, 2026 | Stefan Lutzofficer: Chief Scientific Officer | Sale | 5,862 | $1.13 | 130,421 |
| Feb 6, 2026 | Alison Mooredirector, officer: President and CEO | Sale | 3,826 | $1.31 | 250,506 |
| Feb 6, 2026 | Georgia Erbezofficer: See Remarks | Sale | 3,826 | $1.31 | 66,810 |
| Feb 6, 2026 | Stefan Lutzofficer: Chief Scientific Officer | Sale | 2,492 | $1.31 | 136,283 |
| Jan 7, 2026 | Stefan Lutzofficer: CSO | Sale | 4,685 | $1.70 | 138,775 |
| Nov 7, 2025 | Opaleye Management Inc.10 percent owner | Sale · 3 lots | 603,364 | $1.70 | 240,000 |
| Nov 26, 2025 | Opaleye Management Inc.10 percent owner | Sale · 3 lots | 301,636 | $1.74 | 191,012 |
| Dec 1, 2025 | Opaleye Management Inc.10 percent owner | Sale · 2 lots | 253,533 | $1.67 | 179,989 |
| Nov 28, 2025 | Opaleye Management Inc.10 percent owner | Sale · 2 lots | 107,490 | $1.75 | 188,522 |
House and Senate disclosures
Not reported.